Dr Michael Neef, consultant in paediatric oncology at a large city hospital, is cautiously optimistic when he is given the go-ahead to carry out gene therapy trials on some of his terminally ill patients. The biotechnology company involved believes that it has come up with a treatment for malignant tumours, and the hospital administrators, reeling after a recent bout of bad publicity, see this as an opportunity to get some good press coverage for...